The effects of gene gun delivered pIL-3 adjuvant on skin pathology and cytokine expression

Veterinary Immunology and Immunopathology

Volumn 119, Issue 3-4, 2007, Pages 233-242

  Matthews, K ^a   Rhind, S M ^a   Gossner, A G ^a   Dalziel, R G ^a   Hopkins, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Lymphokines; Sheep; Skin; Vaccination

Indexed keywords

CD45RA ANTIGEN; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 3; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMOEPIDERMAL JUNCTION; EPIDERMIS; FEMALE; GENE GUN; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LYMPHOCYTIC INFILTRATION; NEUTROPHIL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; SKIN ABSCESS; SKIN INFLAMMATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLISTICS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-3; LEUKOCYTES, MONONUCLEAR; PLASMIDS; SHEEP; SHEEP DISEASES; SKIN; SKIN DISEASES;

OVIS ARIES;

EID: 34548381231     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.05.021     Document Type: Article

References (49)

1. Armitage J.O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92 (1998) 4491-4508
2. Beutler B., and Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7 (1989) 625-655
3. Brooke G.P., Parsons K.R., and Howard C.J. Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur. J. Immunol. 28 (1998) 1-11
4. Burgess A.W., and Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56 (1980) 947-958
5. Caux C., Durand I., Moreau I., Duvert V., Saeland S., and Banchereau J. Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors. J. Exp. Med. 177 (1993) 1815-1820
6. Caux C., Massacrier C., Dubois B., Valladeau J., zutter-Dambuyant C., Durand I., Schmitt D., and Saeland S. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J. Leukoc. Biol. 66 (1999) 781-791
7. Caux C., Vanbervliet B., Massacrier C., Durand I., and Banchereau J. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood 87 (1996) 2376-2385
8. Caux C., zutter-Dambuyant C., Schmitt D., and Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360 (1992) 258-261
9. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2 (1996) 1122-1128
10. Coughlan S.N., Harkiss G.D., Dickson L., and Hopkins J. Fc gamma receptor expression on sheep afferent lymph dendritic cells and rapid modulation of cell surface phenotype following Fc gamma receptor engagement in vitro and in vivo. Scand. J. Immunol. 43 (1996) 31-38
11. Cumberbatch M., Bhushan M., Dearman R.J., Kimber I., and Griffiths C.E. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin. Exp. Immunol. 132 (2003) 352-359
12. Daro E., Pulendran B., Brasel K., Teepe M., Pettit D., Lynch D.H., Vremec D., Robb L., Shortman K., McKenna H.J., Maliszewski C.R., and Maraskovsky E. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165 (2000) 49-58
13. Donnahoo K.K., Meng X., Ayala A., Cain M.P., Harken A.H., and Meldrum D.R. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277 (1999) R922-R929
14. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Ann. Rev. Immunol. 15 (1997) 617-648
15. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 175 (2005) 633-639
16. Ferrante A. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors. Immunol. Ser. 57 (1992) 417-436
17. Gonzalez L., Anderson I., Deane D., Summers C., and Buxton D. Detection of immune system cells in paraffin wax-embedded ovine tissues. J. Comp. Pathol. 125 (2001) 41-47
18. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., and Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185 (1997) 1101-1111
19. Hope J.C., Sopp P., Collins R.A., and Howard C.J. Differences in the induction of CD8+ T cell responses by subpopulations of dendritic cells from afferent lymph are related to IL-1 alpha secretion. J. Leukoc. Biol. 69 (2001) 271-279
20. Hopkins J., Ross A.J., and Dutia B.M. Summary of workshop findings for sheep. Vet. Immunol. Immunopathol. 39 (1993) 49-59
21. Howard C.J., and Naessens J. Summary of workshop findings for cattle (tables 1 and 2). Vet. Immunol. Immunopathol. 39 (1993) 25-47
22. Howard C.J., Sopp P., Brownlie J., Kwong L.S., Parsons K.R., and Taylor G. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J. Immunol. 159 (1997) 5372-5382
23. Ihle J.N. Interleukin-3 and hematopoiesis. Chem. Immunol. 51 (1992) 65-106
24. Kvale E.O., Floisand Y., Lund-Johansen F., Rollag H., Farkas L., Ghanekar S., Brandtzaeg P., Jahnsen F.L., and Olweus J. Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. Blood (2006)
25. Lutz M.B. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Immunobiology 209 (2004) 79-87
26. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., and Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30 (2000) 1813-1822
27. Macardle P.J., Chen Z., Shih C.Y., Huang C.M., Weedon H., Sun Q., Lopez A.F., and Zola H. Characterization of human leucocytes bearing the IL-3 receptor. Cell Immunol. 168 (1996) 59-68
28. Maraskovsky E., Daro E., Roux E., Teepe M., Maliszewski C.R., Hoek J., Caron D., Lebsack M.E., and McKenna H.J. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96 (2000) 878-884
29. Maraskovsky E., Pulendran B., Brasel K., Teepe M., Roux E.R., Shortman K., Lyman S.D., and McKenna H.J. Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. Adv. Exp. Med. Biol. 417 (1997) 33-40
30. Matthews K., Bailey S.L., Gossner A.G., Watkins C., Dalziel R.G., and Hopkins J. Gene gun-delivered pGM-CSF adjuvant induces enhanced emigration of two dendritic cell subsets from the skin. Scand. J. Immunol. 65 (2007) 221-229
31. Matthews K., Rhind S.M., Gossner A.G., Dalziel R.G., and Hopkins J. The effect of gene gun-delivered pGM-CSF on the immunopathology of the vaccinated skin. Scand. J. Immunol. 65 (2007) 298-307
32. Mellstedt H., Fagerberg J., Fr÷din J.E., Henriksson L., Hjelm-Skoog A.L., Liljefors M., Ragnhammar P., Shetye J., and Osterborg A. Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors. Curr. Opin. Hematol. 6 (1999) 169-175
33. Moser M., and Murphy K.M. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1 (2001) 199-205
34. Naessens J., Newson J., McHugh N., Howard C.J., Parsons K., and Jones B. Characterization of a bovine leucocyte differentiation antigen of 145,000 MW restricted to B lymphocytes. Immunology 69 (1990) 525-530
35. Perales M.A., Fantuzzi G., Goldberg S.M., Turk M.J., Mortazavi F., Busam K., Houghton A.N., Dinarello C.A., and Wolchok J.D. GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines. Cytokines Cell Mol. Ther. 7 (2002) 125-133
36. Porgador A., Irvine K.R., Iwasaki A., Barber B.H., Restifo N.P., and Germain R.N. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188 (1998) 1075-1082
37. Pulendran B., Banchereau J., Maraskovsky E., and Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22 (2001) 41-47
38. Raz E., Watanabe A., Baird S.M., Eisenberg R.A., Parr T.B., Lotz M., Kipps T.J., and Carson D.A. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4523-4527
39. Rothel J.S., Hurst L., Seow H.F., Pθpin M., Berthon P., Corner L.A., and Wood P.R. Analysis of ovine IL-1 beta production in vivo and in vitro by enzyme immunoassay and immunohistochemistry. Vet. Immunol. Immunopathol. 57 (1997) 267-278
40. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995) 389-400
41. Scheerlinck J.P., Casey G., McWaters P., Kelly J., Woollard D., Lightowlers M.W., Tennent J.M., and Chaplin P.J. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19 (2001) 4053-4060
42. Torres C.A., Iwasaki A., Barber B.H., and Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158 (1997) 4529-4532
43. Tuting T., Storkus W.J., and Falo L.D. DNA immunization targeting the skin: molecular control of adaptive immunity. J. Invest. Dermatol. 111 (1998) 183-188
44. Ulmer J.B., Deck R.R., DeWitt C.M., Friedman A., Donnelly J.J., and Liu M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12 (1994) 1541-1544
45. Warren T.L., and Weiner G.J. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development. Curr. Opin. Hematol. 7 (2000) 168-173
46. Warringa R.A., Koenderman L., Kok P.T., Kreukniet J., and Bruijnzeel P.L. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 77 (1991) 2694-2700
47. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., and Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
48. Xiang Z., and Ertl H.C. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2 (1995) 129-135
49. Yu W.H., Kashani-Sabet M., Liggitt D., Moore D., Heath T.D., and Debs R.J. Topical gene delivery to murine skin. J. Invest. Dermatol. 112 (1999) 370-375